Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06414694
PHASE4
Inpatient Penicillin Delabeling for Low-Risk Patients
Sponsor: University of Tennessee
View on ClinicalTrials.gov
Summary
This study seeks to enroll patients admitted to a children's hospital with identified penicillin allergy. A screening checklist is performed to identify patients with very low or low risk histories of penicillin allergy to offer direct oral challenges to the antibiotic class to de-label patient's with drug allergies.
Key Details
Gender
All
Age Range
2 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2023-09-01
Completion Date
2025-09-30
Last Updated
2024-05-16
Healthy Volunteers
No
Conditions
Interventions
PROCEDURE
Direct Oral Challenge
Direct oral challenge to penicillin at a goal dose of 45 mg/kg given in a 10%/90% dose
Locations (1)
University of Tennessee Health Science Center
Memphis, Tennessee, United States